[1] NICHOLS M, TOWNSEND N, SCARBOROUGH P, et al. Cardiovascular disease in Europe 2014: epidemiological update (vol 35, pg 2950, 2014). Eur Heart J. 2014;35(42):2950-2959.
[2] YEH RW, SIDNEY S, CHANDRA M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155-2165.
[3] SCALISE R, DE SARRO R, CARACCIOLO A, et al. Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value. Med Sci (Basel). 2021;9(1):16.
[4] LAI TM, KUO PJ, LIN CY, et al. CD147 self-regulates matrix metalloproteinase-2 release in gingival fibroblasts after coculturing with U937 monocytic cells. J Periodontol. 2020;91(5):651-660.
[5] PICCOLI MT, GUPTA SK, VIERECK J, et al. Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction. Circ Res. 2017;121(5):575-583.
[6] RAMIREZ-CARRACEDO R, TESORO L, HERNANDEZ I, et al. Ivabradine-Stimulated Microvesicle Release Induces Cardiac Protection against Acute Myocardial Infarction. Int J Mol Sci. 2020;21(18):6566.
[7] GÖMÖRI K, SZABADOS T, KENYERES É, et al. Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors. Int J Mol Sci. 2020;21(19):6990.
[8] GUARNER V, NIETO-LIMA B, CANO-MARTÍNEZ A, et al. GCSF Partially Repairs Heart Damage Induced by Repetitive β-adrenergic Stimulation in Mice: Potential Role of the Mobilized Bone Marrow-derived Cells. Int J Pharmacol. 2007;12(7):689-700.
[9] POURTAJI A, JAHANI V, MOALLEM S, et al. Application of G-CSF in Congestive Heart Failure Treatment. Curr Cardiol Rev. 2019;15(2):83-90.
[10] 龙雨, 邓娟娟, 曹楚珩, 等. 冠状动脉结扎法致大鼠心肌纤维化模型的建立方法探讨[J]. 湖南中医杂志,2018,34(6):158-159.
[11] ORLIC D, KAJSTURA J, CHIMENTI S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98(18):10344-10349.
[12] YE L, D’AGOSTINO G, LOO SJ, et al. Early Regenerative Capacity in the Porcine Heart. Circulation. 2018;138(24):2798-2808.
[13] BO B, LI S, ZHOU K, et al. The Regulatory Role of Oxygen Metabolism in Exercise-Induced Cardiomyocyte Regeneration. Front Cell Dev Biol. 2021;9:664527.
[14] METES-KOSIK N, LUPTAK I, DIBELLO PM, et al. Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-methylation balance. Mol Nutr Food Res. 2012;56(12):1812-1824.
[15] KWON SG, PARK I, KWON YW, et al. Role of stem cell mobilization in the treatment of ischemic diseases. Arch Pharm Res. 2019;42(3):224-231.
[16] TAO Z, TAN S, CHEN W, et al. Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury. J Cardiovasc Transl Res. 2018;11(5): 403-411.
[17] UEDA K, TAKANO H, HASEGAWA H, et al. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol. 2006;26(6):e108-e113.
[18] TAVAKOLI F, OSTAD SN, KHORI V, et al. Outcome improvement of cellular cardiomyoplasty using triple therapy: mesenchymal stem cell+erythropoietin+vascular endothelial growth factor. Eur J Pharmacol. 2013; 714(1-3):456-463.
[19] WANG W, YE S, ZHANG L, et al. Granulocyte colony-stimulating factor attenuates myocardial remodeling and ventricular arrhythmia susceptibility via the JAK2-STAT3 pathway in a rabbit model of coronary microembolization. BMC Cardiovasc Disord. 2020;20(1):85.
[20] FORECHI L, BALDO MP, MEYERFREUND D, et al. Granulocyte colony-stimulating factor improves early remodeling in isoproterenol-induced cardiac injury in rats. Pharmacol Rep. 2012;64(3):643-649.
[21] DECOUX A, LINDSEY ML, VILLARREAL F, et al. Myocardial matrix metalloproteinase-2: inside out and upside down. J Mol Cell Cardiol. 2014;77:64-72.
[22] BRIEST W. Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts. Cardiovasc Res. 2003;57(2):379-387.
[23] CRUZ JO, SILVA AO, RIBEIRO JM, et al. Epigenetic Regulation of the N-Terminal Truncated Isoform of Matrix Metalloproteinase-2 (NTT-MMP-2) and Its Presence in Renal and Cardiac Diseases. Front Genet. 2021;12:637148.
[24] BELL RM, KUNUTHUR SP, HENDRY C. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection. Basic Res Cardiol. 2013;108(2):1-12.
[25] KRZYWONOS-ZAWADZKA A, FRANCZAK A, SAWICKI G, et al. Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury. Cardiol Res Pract. 2020;2020:1561478.
[26] GABISON EE, MOURAH S, STEINFELS E, et al. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction. Am J Pathol. 2005;166(1):209-219.
[27] LAI TM, KUO PJ, LIN CY, et al. CD147 self-regulates matrix metalloproteinase-2 release in gingival fibroblasts after coculturing with U937 monocytic cells. J Periodontol. 2020;91(5):651-660.
[28] AOKI M, KOGA K, HAMASAKI M, et al. Emmprin, released as a microvesicle in epithelioid sarcoma, interacts with fibroblasts. Int J Oncol. 2017;50(6):2229-2235.
[29] LOYER X, ZLATANOVA I, DEVUE C, et al. Intra-Cardiac Release of Extracellular Vesicles Shapes Inflammation Following Myocardial Infarction. Circ Res. 2018; 123(1):100-106.
[30] RAMIREZ-CARRACEDO R, TESORO L, HERNANDEZ I, et al. Ivabradine-Stimulated Microvesicle Release Induces Cardiac Protection against Acute Myocardial Infarction. Int J Mol Sci. 2020;21(18).
[31] HASANEEN NA, CAO J, PULKOSKI-GROSS A, et al. Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts. Respir Res. 2016;17:17.
[32] GYÖRFI AH, MATEI AE, DISTLER J. Targeting TGF-β signaling for the treatment of fibrosis. Matrix Biol. 2018;68-69:8-27.
[33] LI X, CHU G, ZHU F, et al. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7. Exp Cell Res. 2020;386(1):111716.
[34] GONZÁLEZ MN, DEY N, GARG NJ, et al. Granulocyte colony-stimulating factor partially repairs the damage provoked by Trypanosoma cruzi in murine myocardium. Int J Cardiol. 2013;168(3):2567-2574.
[35] GUO Y, SU L, LI Y, et al. The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats. Heart Vessels. 2014;29(4):520-531.
|